Work

A phase 2 trial of ABVD followed by brentuximab vedotin consolidation in limited stage non-bulky Hodgkin lymphoma.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.7508

Authors: Steven I. Park, Oludamilola A. Olajide, Nishitha M. Reddy, L. Elizabeth Budde, Nilanjan Ghosh, Kristy L. Richards, Allison Mary Deal, Jeanne F. Noe, Thomas C. Shea, Stephen Maxted Ansell

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Rex Hospital, Vanderbilt University, Vanderbilt-Ingram Cancer Center, City Of Hope National Medical Center, Carolinas Healthcare System, Cornell University, Weill Cornell Medicine, Mayo Clinic

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891182120

Cites:

Cited by: 4

Related to: 10